May 10 (Reuters) - Hera Med Ltd 1I4.F :
- ANOUSHKA GUNGADIN, RECENTLY APPOINTED AS CEO JOINS BOARD AS MANAGING DIRECTOR
- TIM CHAPMAN APPOINTED AS CHAIR OF BOARD
- TIM CHAPMAN REPLACING RON WEINBERGER AS CHAIR
- BENEFITS OF REDUCTION IN OPERATING COST BASE EXPECTED TO BE REALISED FROM SECOND HALF OF 2024
(([email protected];))
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.63M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $20.76K | 1.038M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 4048472 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 517177 | 1 |
View Market Depth
| Last trade - 15.58pm 08/08/2025 (20 minute delay) ? |
| HMD (ASX) Chart |